TY - JOUR
T1 - Low energy availability in male athletes
T2 - A systematic review of incidence, associations, and effects
AU - McGuire, Amy
AU - Warrington, Giles
AU - Doyle, Lorna
N1 - Publisher Copyright:
© 2020 John Wiley & Sons Ltd
PY - 2020/5/1
Y1 - 2020/5/1
N2 - The Female Athlete Triad has recently been suggested to be a threat to male athletes. This review aims to examine the evidence, and associated effects, of low energy availability (LEA) in male athletes. A comprehensive search of PubMed and SPORTDiscus was performed. Three RCT and seven CS studies were included that measured energy availability and included well-trained males. Clinical LEA (<30 kcal/kg LBM/d) or subclinical LEA (36 ± 6 kcal/kg LBM/d) was evident within all CS studies, documenting 25% of middle- and long-distance runners and racewalkers and 70% of cyclists with LEA. Two out of three RCTs and three out of seven CS studies reported disrupted endocrine functioning, particularly reduced testosterone levels, in association with LEA. One CS study reported that up to 40% of cyclists with LEA had low BMD. One CS study assessed metabolic health, reporting those with suppressed levels spent more time in a severe energy deficit. This review highlights that LEA appears prevalent across male athletic populations, in particular endurance and weight class athletes, and is a potentially serious threat to bone, endocrine, and metabolic health. Future larger scale longitudinal studies, using appropriate study designs, should be undertaken to confirm these threats.
AB - The Female Athlete Triad has recently been suggested to be a threat to male athletes. This review aims to examine the evidence, and associated effects, of low energy availability (LEA) in male athletes. A comprehensive search of PubMed and SPORTDiscus was performed. Three RCT and seven CS studies were included that measured energy availability and included well-trained males. Clinical LEA (<30 kcal/kg LBM/d) or subclinical LEA (36 ± 6 kcal/kg LBM/d) was evident within all CS studies, documenting 25% of middle- and long-distance runners and racewalkers and 70% of cyclists with LEA. Two out of three RCTs and three out of seven CS studies reported disrupted endocrine functioning, particularly reduced testosterone levels, in association with LEA. One CS study reported that up to 40% of cyclists with LEA had low BMD. One CS study assessed metabolic health, reporting those with suppressed levels spent more time in a severe energy deficit. This review highlights that LEA appears prevalent across male athletic populations, in particular endurance and weight class athletes, and is a potentially serious threat to bone, endocrine, and metabolic health. Future larger scale longitudinal studies, using appropriate study designs, should be undertaken to confirm these threats.
KW - bone health
KW - endocrine function
KW - energy availability
KW - exercise physiology
KW - metabolic health
KW - sports nutrition
UR - http://www.scopus.com/inward/record.url?scp=85096565545&partnerID=8YFLogxK
U2 - 10.1002/tsm2.140
DO - 10.1002/tsm2.140
M3 - Review article
AN - SCOPUS:85096565545
SN - 2573-8488
VL - 3
SP - 173
EP - 187
JO - Translational Sports Medicine
JF - Translational Sports Medicine
IS - 3
ER -